Targeting the JAK-STAT Pathway in AD

Alexandra Golant, MD; Christopher Bunick, MD, PhD; and Peter Lio, MD, comment on how targeting the JAK-STAT (signal transducer and activator of transcription) pathway with JAK inhibitors plays a role in managing AD.

Related Keywords

Lisa Swanson ,Alexandra Golant ,Christopher Bunick , ,Peter Lio ,Jak Stat Pathway ,Atopic Dermatitis ,Inhibition Of Cytokine Signaling ,Th11 ,